#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transient ischaemic attack Prolymphocytic leukaemia Neuropathy peripheral Leiomyosarcoma Macular telangiectasia Pleomorphic leiomyosarcoma Hepatic angiosarcoma Glioma Malignant melanoma Chronic myeloid leukaemia (in remission) Advanced systemic mastocytosis Infection in an immunocompromised host Frontotemporal dementia Fabry's disease Pemphigoid More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Diagnostics Myelodysplastic syndrome with excess blasts – Trials in Disease Factor IX deficiency – Life with Disease Medulloblastoma Alexander disease – Basic Information Angiosarcoma non-metastatic – Treatment Mantle cell lymphoma – Diagnostics Lennox-Gastaut syndrome – Life with Disease Fragile X syndrome – Diagnostics Chondrosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tranexamic Acid NERANDOMILAST Betula Verrucosa Pollen Progesterone Ph. Eur. Zolbetuximab CAL101 ATIRMOCICLIB Alpha1H Bi 765845 Abacavir Ep262 Dexamethasone Isonicotinate Levoleucovorin Disodium Milvexian Valemetostat Tosilate Paracetamol Ph. Eur. Tradipitant Calcium Folinate Pentahydrate SODIUM IBANDRONATE Umeclidinium Bromide More therapies…

    Learn about Your Condition

    Immune system disorder Malabsorption Haemorrhage prophylaxis Laryngeal cancer stage II Chondrosarcoma metastatic Irritable bowel syndrome Thymoma Incontinence Non-small cell lung cancer Round cell liposarcoma Bladder cancer stage II Pulmonary fibrosis Laryngeal cancer Tendon disorder Catatonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of obinutuzumab to reduce PLA2R antibodies in patients with primary membranous nephropathy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glomerulonephritis membranous
    Investigated Drugs:
    • Obinutuzumab
    The Netherlands

  • Study of cannabidiol to reduce self-injurious behavior in children and adolescents with severe neurodevelopmental disorders

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Cannabidiol
    France

  • First study of TTX-381 gene therapy safety in patients with eye problems caused by CLN2 disease (Neuronal Ceroid Lipofuscinosis Type 2)

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • TTX-381
    Germany

  • Study of cardiovascular disease prevention using carotid ultrasound in patients with inflammatory rheumatic diseases treated with amlodipine, atorvastatin, rosuvastatin, ezetimibe and bempedoic acid

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatic disorder
    Investigated Drugs:
    • Bempedoic Acid
    • Ezetimibe
    • Atorvastatin
    Spain

  • Study of brentuximab vedotin for maintenance therapy in patients with cutaneous T-cell lymphoma after stem cell transplant

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma
    Investigated Drugs:
    • Brentuximab Vedotin
    France

  • Comparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin Sodium
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    France
Previous Page
1 … 774 775 776 777 778 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!